Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa
Includes bibliographical references. === Treatment for drug-resistant tuberculosis (DR-TB) is longer and associated with more significant side-effects than drug susceptible TB. Second line injectable therapy using kanamycin, amikacin or capreomycin is associated with irreversible hearing loss. There...
Main Author: | Njuguna, Christine Wanjiku |
---|---|
Other Authors: | Cox, Helen |
Format: | Dissertation |
Language: | English |
Published: |
University of Cape Town
2014
|
Subjects: | |
Online Access: | http://hdl.handle.net/11427/10625 |
Similar Items
-
Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa.
by: Helen S Cox, et al.
Published: (2010-01-01) -
Hearing loss amongst dr-tb patients that received extended high frequency pure tone audiometry monitoring (kuduwave) at three dr-tb decentralized sites in Kwazulu-Natal
by: Rudolph-Claasen, Zerilda
Published: (2019) -
Hearing thresholds in patients with drug-resistant tuberculosis: baseline audiogram configurations and associations
by: Olusola Ayodele Sogebi, et al. -
Hearing loss amongst DR-TB patients that have received extended high-frequency pure tone audiometry monitoring (KUDUwave) at three DR-TB decentralized sites in Kwazulu Natal
by: Rudolph-Claasen, Zerilda Suzette
Published: (2019) -
Conflicted cure: explorting concepts of default and adherence in drug resistant tuberculosis patients in Khayelitsha
by: Winterton, Laura
Published: (2014)